NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for August 20131.
Global derivatives average daily volume (“ADV”) of 5.8 million
contracts, excluding Bclear, in August 2013 increased 8.6% compared
to August 2012, but decreased 8.9% from July 2013. U.S. equity
options volumes increased 8.4% compared to August 2012, but
decreased 6.0% sequentially. ADV in European cash equities
increased 17.9% compared to August 2012, but decreased 7.8%
compared to July 2013. U.S. cash equities decreased year-over-year
and month-over-month.
Highlights
- NYSE Euronext global derivatives ADV in
August 2013 of 5.8 million contracts, excluding Bclear, increased
8.6% from August 2012, but decreased 8.9% from July 2013
levels.
- NYSE Euronext European derivatives
products ADV in August 2013 of 2.4 million contracts, excluding
Bclear, increased 10.7% compared to August 2012, but decreased
12.5% from July 2013 levels. Including Bclear, NYSE Liffe’s trade
administration and clearing service for OTC products, European
derivatives ADV decreased 12.5% compared to August 2012, and
decreased 15.6% from July 2013.
- NYSE Euronext U.S. equity options (NYSE
Arca and NYSE Amex Options) ADV of 3.3 million contracts in August
2013 increased 8.4% compared to August 2012 levels, but decreased
6.0% from July 2013 levels. NYSE Euronext’s U.S. options exchanges
accounted for 25.3% of total U.S. consolidated equity options
trading in August 2013, up from 24.8% in August 2012, but down from
26.6% in July 2013.
- NYSE Liffe U.S. ADV of approximately
31,400 contracts decreased from 63,200 contracts in August 2012 and
decreased from 35,000 contracts in July 2013.
- NYSE Euronext European cash products
ADV of 1.3 million transactions in August 2013 increased 17.9%
compared to August 2012 but, decreased 7.8% compared to July
2013.
- NYSE Euronext U.S. cash products (NYSE,
NYSE Arca and NYSE MKT) handled ADV of 1.3 billion shares in August
2013 decreased 7.5% compared to August 2012 and decreased 3.9%
compared to July 2013. NYSE Euronext’s Tape A matched market share
in August 2013 was 30.7%, down from 31.6% in August 2012 but, up
from 30.6% in July 2013.
Please click here for the Monthly Transaction Activity Data
Table.
________________________________
1 All NYSE Euronext derivatives transactions count buy and sell
orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy
and sell orders together as a single transaction.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets - the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.
Please follow us at:Exchanges BlogFacebookLinkedInTwitter
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING
STATEMENTS
This written communication contains “forward-looking statements”
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify forward-looking statements by words such as “may,” “hope,”
“will,” “should,” “expect,” “plan,” “anticipate,” “intend,”
“believe,” “estimate,” “predict,” “potential,” “continue,” “could,”
“future” or the negative of those terms or other words of similar
meaning. You should carefully read forward-looking statements,
including statements that contain these words, because they discuss
our future expectations or state other “forward-looking”
information. Forward-looking statements are subject to numerous
assumptions, risks and uncertainties which change over time. ICE
Group, ICE and NYSE Euronext caution readers that any
forward-looking statement is not a guarantee of future performance
and that actual results could differ materially from those
contained in the forward-looking statement.
Forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving ICE
Group, ICE and NYSE Euronext, including future financial results,
ICE’s and NYSE Euronext’s plans, objectives, expectations and
intentions, the expected timing of completion of the transaction
and other statements that are not historical facts. Important
factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are set forth in
ICE’s and NYSE Euronext’s filings with the U.S. Securities and
Exchange Commission (the “SEC”). These risks and uncertainties
include, without limitation, the following: the inability to close
the merger in a timely manner; the failure to satisfy other
conditions to completion of the merger, including receipt of
required regulatory and other approvals; the failure of the
proposed transaction to close for any other reason; the possibility
that any of the anticipated benefits of the proposed transaction
will not be realized; the risk that integration of NYSE Euronext’s
operations with those of ICE will be materially delayed or will be
more costly or difficult than expected; the challenges of
integrating and retaining key employees; the effect of the
announcement of the transaction on ICE’s, NYSE Euronext’s or the
combined company’s respective business relationships, operating
results and business generally; the possibility that the
anticipated synergies and cost savings of the merger will not be
realized, or will not be realized within the expected time period;
the possibility that the merger may be more expensive to complete
than anticipated, including as a result of unexpected factors or
events; diversion of management’s attention from ongoing business
operations and opportunities; general competitive, economic,
political and market conditions and fluctuations; actions taken or
conditions imposed by the United States and foreign governments or
regulatory authorities; and adverse outcomes of pending or
threatened litigation or government investigations. In addition,
you should carefully consider the risks and uncertainties and other
factors that may affect future results of the combined company, as
are described in the section entitled “Risk Factors” in the joint
proxy statement/prospectus filed by ICE Group with the SEC, and as
described in ICE’s and NYSE Euronext’s respective filings with the
SEC that are available on the SEC’s web site located at
www.sec.gov, including the sections entitled “Risk Factors” in
ICE’s Form 10-K for the fiscal year ended December 31, 2012, as
filed with the SEC on February 6, 2013, and “Risk Factors” in NYSE
Euronext’s Form 10-K for the fiscal year ended December 31, 2012,
as filed with the SEC on February 26, 2013. You should not place
undue reliance on forward-looking statements, which speak only as
of the date of this written communication. Except for any
obligations to disclose material information under the Federal
securities laws, ICE Group, ICE and NYSE Euronext undertake no
obligation to publicly update any forward-looking statements to
reflect events or circumstances after the date of this written
communication.
IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND WHERE
TO FIND IT
This communication does not constitute an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of
any vote or approval. In connection with the proposed transaction,
ICE Group has filed with the SEC a registration statement on Form
S−4, which the SEC has declared effective and which contains a
joint proxy statement/prospectus with respect to the proposed
acquisition of NYSE Euronext by ICE Group. The final joint proxy
statement/prospectus has been delivered to the stockholders of ICE
and NYSE Euronext. INVESTORS AND SECURITY HOLDERS OF BOTH ICE AND
NYSE EURONEXT ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION CAREFULLY
AND IN ITS ENTIRETY, INCLUDING ANY DOCUMENTS PREVIOUSLY FILED WITH
THE SEC AND INCORPORATED BY REFERENCE INTO THE JOINT PROXY
STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO
THOSE DOCUMENTS, BECAUSE IT CONTAINS IMPORTANT INFORMATION
REGARDING ICE, NYSE EURONEXT AND THE PROPOSED TRANSACTION.
Investors and security holders may obtain a free copy of the joint
proxy statement/prospectus, as well as other filings containing
information about ICE and NYSE Euronext, without charge, at the
SEC’s website at http://www.sec.gov. Investors may also obtain
these documents, without charge, from ICE’s website at
http://www.theice.com and from NYSE Euronext’s website at
http://www.nyx.com.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume Total Volume
Average Daily Volume Total
Volume (Unaudited; contracts in thousands)
Aug-13 Aug-12 %
Chg Aug-13
Aug-12 % Chg YTD
2013
% Chg vs. YTD
2012
YTD 2013
% Chg vs. YTD
2012
Number of Trading Days - European Cash 22 23 22 23 170 170
Number of Trading Days - European Derivatives 22 23 22 23 171 171
Number of Trading Days - U.S. Markets 22 23 22 23 168 168
European Derivatives Products
2,841 3,245 -12.5
% 62,495 74,641
-16.3 % 3,970 4.0
% 678,943 2.8 % of which
Bclear 408 1,047 -61.0 % 8,983 24,086 -62.7 % 732 -35.3 % 125,113
-36.1 %
Total Fixed Income Products
1,746 1,432
21.9 % 38,409 32,933
16.6 % 2,428
35.1 % 415,194 33.5
% Short Term Interest Rate Products 1,552 1,268 22.4
% 34,144 29,164 17.1 % 2,247 36.4 % 384,272 34.8 % Medium and Long
Term Interest Rate Products 1 194 164 18.3 % 4,265 3,769 13.2 % 181
20.6 % 30,922 19.2 %
Total Equity Products
2 1,001
1,725 -42.0 % 22,016
39,664 -44.5 %
1,451 -25.0 % 248,065
-25.9 % Individual Equity
Products 632 1,334 -52.7 % 13,897 30,686 -54.7 % 954 -34.4 %
163,162 -35.1 % Futures 289 970 -70.2 % 6,354 22,302 -71.5 % 561
-43.4 % 95,899 -44.1 % Options 343 365 -5.9 % 7,543 8,384 -10.0 %
393 -15.0 % 67,262 -16.0 % Equity Index Products 369 390 -5.5 %
8,119 8,978 -9.6 % 497 3.3 % 84,903 2.1 % of which Bclear
405 1,047 -61.3 % 8,917 24,086 -63.0 % 730 -35.4 % 124,896 -36.2 %
Individual Equity Products 352 992 -64.5 % 7,745 22,821 -66.1 % 633
-40.5 % 108,163 -41.2 % Futures 289 922 -68.7 % 6,354 21,196 -70.0
% 546 -43.4 % 93,443 -44.0 % Options 63 71 -10.5 % 1,391 1,625
-14.4 % 86 -12.6 % 14,720 -13.6 % Equity Index Products 53 55 -3.1
% 1,172 1,265 -7.3 % 98 43.4 % 16,733 41.7 %
Commodity Products 94
89 5.9 % 2,070
2,045 1.3 %
92 6.6 % 15,684
5.4 %
U.S. Derivatives
Products
Equity Options 3
NYSE Euronext Options Contracts 3,347 3,088 8.4 %
73,627 71,035 3.6 % 4,083 6.7 % 685,894 6.0 % Total Consolidated
Options Contracts 13,237 12,439 6.4 % 291,214 286,101 1.8 % 14,889
0.9 % 2,501,420 0.4 % NYSE Group Share of Total 25.3 % 24.8
% 25.3 % 24.8 % 27.4 % 1.5 % 27.4 % 1.5 %
NYSE
Liffe U.S.
Futures and Futures Options Volume*
31.4 63.2 -50.3 % 691 1,453 -52.5 % 53.8 -31.1 % 9,248.1 -31.5 %
European Cash Products (trades in thousands)
1,281 1,086
17.9 % 28,185
24,985 12.8 % 1,401
-9.4 % 238,166
-10.5 % Equities 1,237 1,045 18.4 % 27,221
24,033 13.3 % 1,351 -9.6 % 229,743 -10.7 % Exchange-Traded Funds 12
11 10.1 % 273 259 5.3 % 14 0.0 % 2,349 -1.1 % Structured Products
28 26 10.6 % 621 587 5.8 % 31 -3.7 % 5,252 -4.8 % Bonds 3 5 -31.4 %
70 106 -34.4 % 5 -3.3 % 821 -4.4 %
U.S. Cash
Products (shares in millions) 5
1,339 1,447 -7.4
% 29,465 33,275
-11.4 % 1,529 -11.9
% 256,891 -12.5 %
NYSE Listed (Tape A) Issues 4
Handled Volume 5 945 1,023 -7.7 % 20,788 23,537 -11.7 % 1,093 -11.8
% 183,617 -12.4 % Matched Volume 6 913 969 -5.7 % 20,094 22,286
-9.8 % 1,053 -10.3 % 176,935 -10.9 % Total NYSE Listed Consolidated
Volume 2,971 3,067 -3.2 % 65,353 70,550 -7.4 % 3,452 -7.8 % 579,949
-8.3 %
Share of Total Consolidated Volume Handled
Volume 5 31.8 % 33.4 % -1.6 % 31.8 % 33.4 % -1.6 % 31.7 % -1.5 %
31.7 % -1.5 % Matched Volume 6 30.7 % 31.6 % -0.9 % 30.7 % 31.6 %
-0.9 % 30.5 % -0.9 % 30.5 % -0.9 %
NYSE Arca, MKT
and Regional (Tape B) Listed Issues
Handled Volume 5 232 197 17.9 % 5,115 4,537 12.7 % 250 -2.9 %
41,946 -3.5 % Matched Volume 6 214 179 19.6 % 4,719 4,126 14.4 %
230 -0.5 % 38,646 -1.1 % Total NYSE Arca & MKT Listed
Consolidated Volume 1,008 820 22.9 % 22,183 18,870 17.6 % 1,094 0.7
% 183,861 0.1 %
Share of Total Consolidated Volume
Handled Volume 5 23.1 % 24.0 % -0.9 % 23.1 % 24.0 % -0.9 % 22.8 %
-0.8 % 22.8 % -0.8 % Matched Volume 6 21.3 % 21.9 % -0.6 % 21.3 %
21.9 % -0.6 % 21.0 % -0.2 % 21.0 % -0.2 %
Nasdaq
Listed (Tape C) Issues
Handled Volume 5 162 226
-28.4 % 3,563 5,201 -31.5 % 186 -22.2 % 31,328 -22.7 % Matched
Volume 6 145 195 -25.8 % 3,185 4,484 -29.0 % 167 -18.7 % 27,991
-19.2 % Total Nasdaq Listed Consolidated Volume 1,508 1,562 -3.4 %
33,173 35,920 -7.6 % 1,740 -0.4 % 292,394 -1.0 %
Share of
Total Consolidated Volume Handled Volume 5 10.7 % 14.5 % -3.8 %
10.7 % 14.5 % -3.8 % 10.7 % -3.0 % 10.7 % -3.0 % Matched Volume 6
9.6 % 12.5 % -2.9 % 9.6 % 12.5 % -2.9 % 9.6 % -2.1 % 9.6 % -2.1 %
Exchange-Traded Products 5,7
Handled Volume 5 216 184 17.5 % 4,757 4,234 12.4 % 234 -3.1
% 39,322 -3.7 % Matched Volume 6 200 168 19.2 % 4,397 3,856 14.0 %
216 -0.6 % 36,224 -1.2 % Total ETF Consolidated Volume 944 788 19.7
% 20,766 18,130 14.5 % 1,050 -0.3 % 176,344 -0.9 %
Share
of Total Consolidated Volume Handled Volume 5 22.9 % 23.4 %
-0.5 % 22.9 % 23.4 % -0.5 % 22.3 % -0.6 % 22.3 % -0.6 % Matched
Volume 6 21.2 % 21.3 % -0.1 % 21.2 % 21.3 % -0.1 % 20.5 % -0.1 %
20.5 % -0.1 % 1 Data includes currency products. 2
Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives. 3 Includes trading in U.S.
equity options contracts, not equity-index options. 4 Includes all
volume executed in NYSE Group crossing sessions. 5 Represents the
total number of shares of equity securities and ETFs internally
matched on the NYSE Group's exchanges or routed to and executed at
an external market center. NYSE Arca routing includes odd-lots. 6
Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges. 7 Data included in
previously identified categories. * ADVs calculated with the
appropriate number of NYSE Liffe U.S. trading days. Source: NYSE
Euronext, Options Clearing Corporation and Consolidated Tape as
reported for equity securities. All trading activity is
single-counted, except European cash trading which is double
counted to include both buys and sells.
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Lug 2023 a Lug 2024